Unaudited Condensed Statements of Stockholders’ Equity (Deficit) - USD ($)
|
Total |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
| Balance (in shares) at Dec. 31, 2017 |
[1] |
|
11,888,240
|
|
|
| Balance at Dec. 31, 2017 |
|
$ (12,174,614)
|
$ 11,888
|
$ 7,167,189
|
$ (19,353,691)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Issuance of common stock (in shares) |
[1] |
|
7,111,631
|
|
|
| Issuance of common stock and warrants |
|
16,137,661
|
$ 711
|
16,136,950
|
|
| Stock issuance costs |
|
(2,568,079)
|
|
(2,568,079)
|
|
| Share-based compensation |
|
7,174,000
|
|
7,174,000
|
|
| Net loss |
|
(14,959,744)
|
|
|
(14,959,744)
|
| Change in par value from $0.001 to $0.0001 |
|
0
|
$ (10,699)
|
10,699
|
|
| Issuance of shares as a result of reverse recapitalization (in shares) |
[1] |
|
1,864,808
|
|
|
| Issuance of shares as a result of reverse recapitalization |
|
(978,674)
|
$ 186
|
(978,860)
|
|
| Warrants issued with common stock |
|
1,995,000
|
|
1,995,000
|
|
| Warrants issued to placement agents |
|
913,000
|
|
913,000
|
|
| Conversion of convertible debt and accrued interest (in shares) |
[1] |
|
4,827,001
|
|
|
| Conversion of convertible debt and accrued interest |
|
9,229,819
|
$ 483
|
9,229,336
|
|
| Beneficial conversion feature |
|
3,077,887
|
|
3,077,887
|
|
| Balance (in shares) at Mar. 31, 2018 |
[1] |
|
25,691,680
|
|
|
| Balance at Mar. 31, 2018 |
|
7,846,256
|
$ 2,569
|
42,157,122
|
(34,313,435)
|
| Balance (in shares) at Dec. 31, 2017 |
[1] |
|
11,888,240
|
|
|
| Balance at Dec. 31, 2017 |
|
(12,174,614)
|
$ 11,888
|
7,167,189
|
(19,353,691)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net loss |
|
(19,951,226)
|
|
|
|
| Balance (in shares) at Sep. 30, 2018 |
[1] |
|
25,983,538
|
|
|
| Balance at Sep. 30, 2018 |
|
380,800
|
$ 2,598
|
39,683,119
|
(39,304,917)
|
| Balance (in shares) at Mar. 31, 2018 |
[1] |
|
25,691,680
|
|
|
| Balance at Mar. 31, 2018 |
|
7,846,256
|
$ 2,569
|
42,157,122
|
(34,313,435)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Share-based compensation |
|
(184,000)
|
|
(184,000)
|
|
| Net loss |
|
(4,215,552)
|
|
|
(4,215,552)
|
| Exercise of warrants (in shares) |
[1] |
|
3,922
|
|
|
| Exercise of warrants, net of commissions |
|
12,472
|
$ 1
|
12,471
|
|
| Balance (in shares) at Jun. 30, 2018 |
[1] |
|
25,695,602
|
|
|
| Balance at Jun. 30, 2018 |
|
3,459,176
|
$ 2,570
|
41,985,593
|
(38,528,987)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Share-based compensation |
|
(3,131,000)
|
|
(3,131,000)
|
|
| Net loss |
|
(775,930)
|
|
|
(775,930)
|
| Exercise of warrants (in shares) |
[1] |
|
287,936
|
|
|
| Exercise of warrants, net of commissions |
|
828,554
|
$ 28
|
828,526
|
|
| Balance (in shares) at Sep. 30, 2018 |
[1] |
|
25,983,538
|
|
|
| Balance at Sep. 30, 2018 |
|
380,800
|
$ 2,598
|
39,683,119
|
(39,304,917)
|
| Balance (in shares) at Dec. 31, 2018 |
|
|
26,088,820
|
|
|
| Balance at Dec. 31, 2018 |
|
(3,659,064)
|
$ 2,609
|
39,854,297
|
(43,515,970)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Issuance of common stock (in shares) |
|
|
4,886,782
|
|
|
| Issuance of common stock and warrants |
|
11,475,255
|
$ 489
|
11,474,766
|
|
| Allocation of warrants to liabilities |
|
(1,970,000)
|
|
(1,970,000)
|
|
| Stock issuance costs |
|
(319,819)
|
|
(319,819)
|
|
| Share-based compensation |
|
526,000
|
|
526,000
|
|
| Issuance of RSUs (in shares) |
|
|
90,000
|
|
|
| Issuance of RSUs |
|
0
|
$ 9
|
(9)
|
|
| Net loss |
|
(4,434,765)
|
|
|
(4,434,765)
|
| Balance (in shares) at Mar. 31, 2019 |
|
|
31,065,602
|
|
|
| Balance at Mar. 31, 2019 |
|
1,617,607
|
$ 3,107
|
49,565,235
|
(47,950,735)
|
| Balance (in shares) at Dec. 31, 2018 |
|
|
26,088,820
|
|
|
| Balance at Dec. 31, 2018 |
|
(3,659,064)
|
$ 2,609
|
39,854,297
|
(43,515,970)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Net loss |
|
(18,144,237)
|
|
|
|
| Balance (in shares) at Sep. 30, 2019 |
|
|
35,883,953
|
|
|
| Balance at Sep. 30, 2019 |
|
(3,314,923)
|
$ 3,589
|
58,341,695
|
(61,660,207)
|
| Balance (in shares) at Mar. 31, 2019 |
|
|
31,065,602
|
|
|
| Balance at Mar. 31, 2019 |
|
1,617,607
|
$ 3,107
|
49,565,235
|
(47,950,735)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Issuance of common stock (in shares) |
|
|
4,318,272
|
|
|
| Issuance of common stock and warrants |
|
8,744,501
|
$ 432
|
8,744,069
|
|
| Allocation of warrants to liabilities |
|
(1,360,000)
|
|
(1,360,000)
|
|
| Stock issuance costs |
|
(389,623)
|
|
(389,623)
|
|
| Share-based compensation |
|
852,000
|
|
852,000
|
|
| Exercise of stock options (in shares) |
|
|
100,079
|
|
|
| Exercise of stock options |
|
30,064
|
$ 10
|
30,054
|
|
| Issuance of RSUs (in shares) |
|
|
400,000
|
|
|
| Issuance of RSUs |
|
0
|
$ 40
|
(40)
|
|
| Net loss |
|
(4,488,240)
|
|
|
(4,488,240)
|
| Balance (in shares) at Jun. 30, 2019 |
|
|
35,883,953
|
|
|
| Balance at Jun. 30, 2019 |
|
5,006,309
|
$ 3,589
|
57,441,695
|
(52,438,975)
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
| Share-based compensation |
|
900,000
|
|
900,000
|
|
| Net loss |
|
(9,221,232)
|
|
|
(9,221,232)
|
| Balance (in shares) at Sep. 30, 2019 |
|
|
35,883,953
|
|
|
| Balance at Sep. 30, 2019 |
|
$ (3,314,923)
|
$ 3,589
|
$ 58,341,695
|
$ (61,660,207)
|
|
|